KRYSTAL KENNEDY: Open Payments
NPI 1598363681 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,630 in 84 payments from 19 companies in 2025. Trend: 2023 $2,050 · 2024 $1,035 · 2025 $1,630
Food & beverage: $1,630
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $312 |
| Novartis Pharmaceuticals Corporation | 19 | $300 |
| Regeneron Healthcare Solutions, Inc. | 10 | $194 |
| CSL Behring | 7 | $173 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $110 |
| GlaxoSmithKline, LLC. | 5 | $84 |
| Boston Scientific Corporation | 2 | $65 |
| Cycle Pharmaceuticals Inc | 3 | $61 |
| Genentech USA, Inc. | 3 | $58 |
| GENZYME CORPORATION | 2 | $45 |
Products named: DUPIXENT, AIRSUPRA, XOLAIR, NEFFY, Rhapsido, FASENRA, Hizentra, NUCALA.
Industry payments across NC — which companies pay providers there.
